Felbinac
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C14H12O2 |
Molar mass | 212.244 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Felbinac |
Articles |
---|
Most recent articles on Felbinac |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Felbinac at Clinical Trials.gov Clinical Trials on Felbinac at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Felbinac
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Felbinac Risk calculators and risk factors for Felbinac
|
Healthcare Provider Resources |
Causes & Risk Factors for Felbinac |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Felbinac (INN, or biphenylylacetic acid) is a topical medicine, belonging to the family of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs) of the arylpropionic acid class, which is used to treat muscle inflammation and arthritis. It is an active metabolite of fenbufen.[1]
References
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Drugboxes which contain changes to watched fields
- Non-steroidal anti-inflammatory drugs
- Drug